Filing Details
- Accession Number:
- 0001415889-23-014916
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-08 17:55:47
- Reporting Period:
- 2023-11-06
- Accepted Time:
- 2023-11-08 17:55:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
855654 | Immunogen Inc. | IMGN | Pharmaceutical Preparations (2834) | 042726691 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1838777 | Renee Lentini | C/O Immunogen, Inc. 830 Winter Street Waltham MA 02451 | Vp & Prin Acctg Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-11-06 | 9,000 | $10.79 | 108,017 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-11-06 | 2,619 | $2.68 | 110,636 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-11-06 | 23,000 | $10.65 | 133,636 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-11-06 | 14,373 | $5.25 | 148,009 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-11-06 | 4,024 | $6.98 | 152,033 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-11-06 | 55,550 | $7.69 | 207,583 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-11-06 | 11,962 | $5.32 | 219,545 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-11-06 | 219,545 | $15.29 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2023-11-06 | 9,000 | $0.00 | 9,000 | $10.79 |
Common Stock | Stock Option (right to buy) | Disposition | 2023-11-06 | 2,619 | $0.00 | 2,619 | $2.68 |
Common Stock | Stock Option (right to buy) | Disposition | 2023-11-06 | 23,000 | $0.00 | 23,000 | $10.65 |
Common Stock | Stock Option (right to buy) | Disposition | 2023-11-06 | 14,373 | $0.00 | 14,373 | $5.25 |
Common Stock | Stock Option (right to buy) | Disposition | 2023-11-06 | 4,024 | $0.00 | 4,024 | $6.98 |
Common Stock | Stock Option (right to buy) | Disposition | 2023-11-06 | 55,550 | $0.00 | 55,550 | $7.69 |
Common Stock | Stock Option (right to buy) | Disposition | 2023-11-06 | 11,962 | $0.00 | 11,962 | $5.32 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2024-07-17 | No | 4 | M | Direct | |
0 | 2026-09-30 | No | 4 | M | Direct | |
0 | 2028-02-15 | No | 4 | M | Direct | |
0 | 2029-01-31 | No | 4 | M | Direct | |
12,625 | 2031-01-08 | No | 4 | M | Direct | |
25,250 | 2031-02-05 | No | 4 | M | Direct | |
53,831 | 2032-02-04 | No | 4 | M | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
- This option was granted on 7/17/2014 and is fully vested as of the transaction date.
- This option was granted on 9/30/2016 and is fully vested as of the transaction date.
- This option was granted on 2/15/2018 and is fully vested as of the transaction date.
- This option was granted on 1/31/2019 and is fully vested as of the transaction date.
- This option was granted on 1/8/2021 and is exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years.
- This option was granted on 2/5/2021 and is exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years.
- This option was granted on 2/4/2022 and is exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years.